{"id":"https://openalex.org/W2995486702","doi":"https://doi.org/10.1080/24734306.2019.1700339","title":"Agreement between self-reported psychoactive substance use and urine toxicology results for adults with opioid use disorder admitted to hospital","display_name":"Agreement between self-reported psychoactive substance use and urine toxicology results for adults with opioid use disorder admitted to hospital","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2995486702","doi":"https://doi.org/10.1080/24734306.2019.1700339","mag":"2995486702","pmid":"https://pubmed.ncbi.nlm.nih.gov/32051924","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7015152"},"language":"en","primary_location":{"id":"doi:10.1080/24734306.2019.1700339","doi":"https://doi.org/10.1080/24734306.2019.1700339","is_oa":true,"landing_page_url":"https://doi.org/10.1080/24734306.2019.1700339","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/24734306.2019.1700339?needAccess=true","source":{"id":"https://openalex.org/S4210233781","display_name":"Toxicology Communications","issn_l":"2473-4306","issn":["2473-4306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Communications","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/24734306.2019.1700339?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082521111","display_name":"Jessica L. Moreno","orcid":"https://orcid.org/0000-0003-0515-2989","observed_orcids":["https://orcid.org/0000-0003-0515-2989"]},"institutions":[{"id":"https://openalex.org/I2799370151","display_name":"Beaumont Health","ror":"https://ror.org/05g2hd893","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2799370151","https://openalex.org/I4392738273"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica L. Moreno","raw_affiliation_strings":["Department of Quality Management and Patient Safety, Beaumont Health, Southfield, MI, USA;","Substance Use Disorders Initiative, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quality Management and Patient Safety, Beaumont Health, Southfield, MI, USA;","institution_ids":["https://openalex.org/I2799370151"]},{"raw_affiliation_string":"Substance Use Disorders Initiative, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018500786","display_name":"Matthew S. Duprey","orcid":"https://orcid.org/0000-0002-2365-431X","observed_orcids":["https://orcid.org/0000-0002-2365-431X"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew S. Duprey","raw_affiliation_strings":["School of Pharmacy, Northeastern University, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Northeastern University, Boston, MA, USA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004359182","display_name":"Bryan D. Hayes","orcid":"https://orcid.org/0000-0001-7349-6770","observed_orcids":["https://orcid.org/0000-0001-7349-6770"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan D. Hayes","raw_affiliation_strings":["Department of Emergency Medicine, Harvard Medical School, Boston, MA, USA;","Department of Pharmacy, Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Emergency Medicine, Harvard Medical School, Boston, MA, USA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pharmacy, Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050267874","display_name":"Kirsten Brooks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirsten Brooks","raw_affiliation_strings":["School of Pharmacy, Northeastern University, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Northeastern University, Boston, MA, USA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061227073","display_name":"Sabrina Khalil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabrina Khalil","raw_affiliation_strings":["School of Pharmacy, Northeastern University, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Northeastern University, Boston, MA, USA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065387807","display_name":"Sarah E. Wakeman","orcid":"https://orcid.org/0000-0002-5475-2713","observed_orcids":["https://orcid.org/0000-0002-5475-2713"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah E. Wakeman","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA;","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Russell J. Roberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell J. Roberts","raw_affiliation_strings":["Department of Pharmacy, Massachusetts General Hospital, Boston, MA;","School of Pharmacy, Northeastern University, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"School of Pharmacy, Northeastern University, Boston, MA, USA;","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008055843","display_name":"Jared S. Jacobson","orcid":"https://orcid.org/0000-0002-3846-8544","observed_orcids":["https://orcid.org/0000-0002-3846-8544"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jared S. Jacobson","raw_affiliation_strings":["Department of Health Sciences, Northeastern University, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences, Northeastern University, Boston, MA, USA","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014524643","display_name":"John W. Devlin","orcid":"https://orcid.org/0000-0003-1751-9012","observed_orcids":["https://orcid.org/0000-0003-1751-9012"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John W. Devlin","raw_affiliation_strings":["School of Pharmacy, Northeastern University, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Northeastern University, Boston, MA, USA;","institution_ids":["https://openalex.org/I12912129"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5014524643"],"corresponding_institution_ids":["https://openalex.org/I12912129"],"apc_list":{"value":635,"currency":"GBP","value_usd":778},"apc_paid":{"value":635,"currency":"GBP","value_usd":778},"fwci":0.9205,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.76380215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"3","issue":"1","first_page":"94","last_page":"101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.8672000169754028,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.8672000169754028,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.09920000284910202,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.02850000001490116,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/urine-drug-testing","display_name":"urine drug testing","score":0.8289999961853027},{"id":"https://openalex.org/keywords/self-reported-substance-use","display_name":"self-reported substance use","score":0.9599999785423279},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.8040000200271606},{"id":"https://openalex.org/keywords/opiates","display_name":"opiates","score":0.6320000290870667},{"id":"https://openalex.org/keywords/heroin","display_name":"heroin","score":0.6840000152587891},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9909999966621399},{"id":"https://openalex.org/keywords/6-monoacetylmorphine","display_name":"6-monoacetylmorphine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.8080000281333923},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.984000027179718},{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":0.4830000102519989},{"id":"https://openalex.org/keywords/cannabinoids","display_name":"cannabinoids","score":0.9750000238418579},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.6579999923706055},{"id":"https://openalex.org/keywords/barbiturates","display_name":"barbiturates","score":0.9620000123977661},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/illicit-fentanyl","display_name":"illicit fentanyl","score":0.671999990940094},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.7708761692047119},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.6920922994613647},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6820163726806641},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5900935530662537},{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.5360174179077148},{"id":"https://openalex.org/C2776029756","wikidata":"https://www.wikidata.org/wiki/Q407535","display_name":"Oxycodone","level":4,"score":0.529008686542511},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.479386568069458},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.46153056621551514},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.45640480518341064},{"id":"https://openalex.org/C158342456","wikidata":"https://www.wikidata.org/wiki/Q587862","display_name":"Forensic toxicology","level":2,"score":0.4428520202636719},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.438988596200943},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.43294796347618103},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.4327763617038727},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.281116247177124},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22614678740501404},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1080/24734306.2019.1700339","doi":"https://doi.org/10.1080/24734306.2019.1700339","is_oa":true,"landing_page_url":"https://doi.org/10.1080/24734306.2019.1700339","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/24734306.2019.1700339?needAccess=true","source":{"id":"https://openalex.org/S4210233781","display_name":"Toxicology Communications","issn_l":"2473-4306","issn":["2473-4306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Communications","raw_type":"journal-article"},{"id":"pmid:32051924","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32051924","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology communications","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7015152","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7015152","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Toxicol Commun","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1080/24734306.2019.1700339","doi":"https://doi.org/10.1080/24734306.2019.1700339","is_oa":true,"landing_page_url":"https://doi.org/10.1080/24734306.2019.1700339","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/24734306.2019.1700339?needAccess=true","source":{"id":"https://openalex.org/S4210233781","display_name":"Toxicology Communications","issn_l":"2473-4306","issn":["2473-4306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8799999952316284}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2845880296","display_name":"Preventing ICU Subsyndromal Delirium Conversion to Delirium with Haloperidol","funder_award_id":"R15AG034915","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2995486702.pdf"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W2006747400","https://openalex.org/W2033968111","https://openalex.org/W2132261446","https://openalex.org/W2138473951","https://openalex.org/W2253478477","https://openalex.org/W2292748019","https://openalex.org/W2566008482","https://openalex.org/W2597794375","https://openalex.org/W2724984227","https://openalex.org/W2752753832","https://openalex.org/W2753936679","https://openalex.org/W2776828305","https://openalex.org/W2906591149","https://openalex.org/W2909076047","https://openalex.org/W2940977491","https://openalex.org/W2947027702"],"related_works":["https://openalex.org/W7221377445","https://openalex.org/W4413791557","https://openalex.org/W3175183069","https://openalex.org/W2788063324","https://openalex.org/W4404769562","https://openalex.org/W4316126875","https://openalex.org/W71828487","https://openalex.org/W1964621470","https://openalex.org/W2068175063","https://openalex.org/W1974626055"],"abstract_inverted_index":{"Hospitals":[0],"often":[1],"perform":[2],"urine":[3],"drug":[4],"screens":[5],"(UDS)":[6],"upon":[7],"inpatient":[8],"admission":[9],"to":[10,25,45,69,103],"confirm":[11],"self-reported":[12,164],"psychoactive":[13,35,187],"substance":[14,49,106,188],"use":[15,20,166,189],"for":[16,34,40,65,134,149],"patients":[17,173,181],"with":[18,38,42,73,182,196],"opioid":[19],"disorder":[21],"(OUD).":[22],"We":[23],"sought":[24],"evaluate":[26],"the":[27,55,58,79,85,197],"agreement":[28,53,83,160,184],"between":[29,54,185],"UDS":[30,39,56,192],"and":[31,57,125,139,154,191,202],"patient":[32],"self-report":[33],"substances":[36],"detected":[37],"adults":[41,67],"OUD":[43],"admitted":[44,68],"hospital.":[46],"For":[47],"11":[48],"categories,":[50],"we":[51],"evaluated":[52],"documented":[59],"history":[60,75,190],"over":[61,161],"a":[62,74],"5-year":[63],"period":[64],"consecutive":[66],"one":[70],"academic":[71],"center":[72],"of":[76,163,172,199],"OUD.":[77],"Among":[78,179],"153":[80],"patients,":[81],"overall":[82],"across":[84],"1683":[86],"different":[87],"history/UDS":[88],"pairs":[89],"(i.e.":[90],"either":[91],"history+/UDS":[92],"+":[93,143],"or":[94],"history-/UDS-)":[95],"was":[96],"high":[97],"(81.3%)":[98],"but":[99],"varied":[100],"(from":[101],"lowest":[102],"highest)":[104],"by":[105],"[opiates":[107],"(56.9%),":[108],"benzodiazepines":[109,152],"(66.0%),":[110],"6-acetylmorphine":[111,135],"(67.3%),":[112],"cocaine":[113],"(81.0%),":[114,116],"cannabinoids":[115,155],"methadone":[117,137],"(83.7%),":[118],"buprenorphine":[119],"(85.0%),":[120],"amphetamine":[121],"(94.8%),":[122],"barbiturates":[123],"(95.4%),":[124],"phencyclidine":[126],"(98.7%)].":[127],"History+/UDS-":[128],"pair":[129,144],"mismatches":[130,145],"were":[131,146],"most":[132,147],"frequent":[133,148],"(32.7%),":[136],"(14.3%)":[138],"oxycodone":[140],"(12.4%);":[141],"history-/UDS":[142],"opiates":[150],"(43.1%),":[151],"(24.8%)":[153],"(18.3%).":[156],"The":[157],"change":[158],"in":[159],"time":[162],"heroin":[165],"may":[167],"reflect":[168],"an":[169],"increasing":[170],"number":[171],"unknowingly":[174],"using":[175],"illicit":[176],"fentanyl":[177],"products.":[178],"hospitalized":[180],"OUD,":[183],"reported":[186],"results":[193],"is":[194],"strong":[195],"exception":[198],"opiates,":[200],"heroin,":[201],"benzodiazepines.":[203]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2019-12-26T00:00:00"}